Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
Среда моделирования для оценки систем замкнутой доставки инсулина при сахарном диабете 1 типа
2010-01-01
SCID: 54.1/cryrych4
Discuss with AI
closed-loop insulin deliveryin silico simulationmodel predictive controltype 1 diabetes mellitusvirtual patient population
Figures from the paper
Abstract (AI)
BACKGROUND: Closed-loop insulin delivery systems linking subcutaneous insulin infusion to real-time continuous glucose monitoring need to be evaluated in humans, but progress can be accelerated with the use of in silico testing. We present a simulation environment designed to support the development and testing of closed-loop insulin delivery systems in type 1 diabetes mellitus (T1DM). METHODS: The principal components of the simulation environment include a mathematical model of glucose regulation representing a virtual population with T1DM, the glucose measurement model, and the insulin delivery model. The simulation environment is highly flexible. The user can specify an experimental protocol, define a population of virtual subjects, choose glucose measurement and insulin delivery models, and specify outcome measures. The environment provides graphical as well as numerical outputs to enable a comprehensive analysis of in silico study results. The simulation environment is validated by comparing its predictions against a clinical study evaluating overnight closed-loop insulin delivery in young people with T1DM using a model predictive controller. RESULTS: The simulation model of glucose regulation is described, and population values of 18 synthetic subjects are provided. The validation study demonstrated that the simulation environment was able to reproduce the population results of the clinical study conducted in young people with T1DM. CONCLUSIONS: Closed-loop trials in humans should be preceded and concurrently guided by highly efficient and resource-saving computer-based simulations. We demonstrate validity of population-based predictions obtained with our simulation environment.
Key Findings
1
The environment includes 18 synthetic subjects representing a virtual population with type 1 diabetes.
2
The environment integrates a mathematical glucose-regulation model, glucose measurement model, and insulin delivery model for virtual patients.
3
The findings support using computer-based simulations before and alongside human closed-loop trials to improve efficiency and reduce resource requirements.
4
The paper introduces a flexible in silico simulation environment for developing and testing closed-loop insulin delivery systems in type 1 diabetes.
5
Users can define experimental protocols, virtual populations, sensing and delivery models, and outcome measures, with graphical and numerical outputs.
6
Validation against a clinical overnight closed-loop study in young people with type 1 diabetes reproduced the clinical population-level results.
Research Object
closed-loop insulin delivery systems in people with type 1 diabetes mellitus, represented by a virtual T1DM population
Research Subject
the systems’ glucose-regulation performance and population-level prediction validity in in silico testing
Publication Details
Publication Date
2010-01-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
283
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by6
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study2017
Closed-loop insulin delivery for treatment of type 1 diabetes2011
The Artificial Pancreas and Meal Control: An Overview of Postprandial Glucose Regulation in Type 1 Diabetes2018
Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy2020
A model-based approach to synthesizing insulin infusion pump usage parameters for diabetic patients2012
Intra-patient dynamic variations in Type 1 Diabetes: A review2016